FAA Proposes Easing Medical Certification for Pilots with Non-Insulin-Treated Diabetes
The Federal Aviation Administration (FAA) has proposed changes to its medical certification requirements that could make it easier for pilots with non-insulin-treated diabetes mellitus (NIDDM) to obtain or maintain an aviation medical certificate. Under the proposal, many applicants could be assessed directly by Aviation Medical Examiners (AMEs) without requiring an FAA special-issuance review.
The proposed rule reflects advances in diabetes treatment, monitoring, and risk management since the current standards were introduced in 1959. While pilots who require insulin would continue to undergo FAA special-issuance assessment, the changes could reduce administrative burdens, shorten certification timelines, and benefit thousands of applicants each year while maintaining aviation safety standards.
Published: 15 September 2026
Written by: Shreya Majumder
Many pilots with non-insulin-treated diabetes might be certified by AMEs under the proposed rule without requiring an FAA special-issuance assessment. Pilots with non-insulin-treated diabetes may find it easier to obtain or retain an aviation medical certificate if the Federal Aviation Administration (FAA) modifies its medical certification rules.
Instead of automatically sending applicants' cases to the FAA for special-issuance review, the proposed rule would allow Aviation Medical Examiners (AMEs) to assess and certify applicants with non-insulin-dependent diabetes mellitus (NIDDM) during their medical examination. On September 4, 2026, the FAA released the Notice of Proposed Rulemaking (NPRM), with a deadline of October 5 for public comments.
Changes to the Current Medical Standard
Applicants with a medical history of diabetes who need insulin or specific other hypoglycaemic drugs are subject to further FAA evaluation under FAR 67.401 under the current regulations. The Federal Air Surgeon then determines their certification through the special-issuance process.
A more targeted medical criterion would take the place of the current medication-based language in the proposed regulation. Applicants with diabetes mellitus who require insulin for control would be subject to the main restriction under the revised approach. As a result, AMEs would have greater authority to evaluate applicants with diabetes who are not receiving insulin through the standard medical certification process.
Crucially, the proposal does not remove the requirement for pilots with diabetes who need insulin to receive special issuance. The FAA would still assess those applicants. Additionally, when necessary, AMEs would still be able to refer higher-risk cases of non-insulin-treated diabetes to the FAA.
Reflecting Advances in Diabetes Management
The FAA claims that since the current medical standard was created in 1959, there have been substantial advancements in the management and treatment of diabetes, which is reflected in the proposed revision.
The FAA is reevaluating whether the current certification system remains appropriate for pilots whose condition is managed without insulin due to significant changes in modern diabetes care, monitoring, and medication.
The FAA reviewed 51 fatal accidents involving pilots using non-insulin diabetes medicines between 2008 and 2025. One case is still being investigated, but the agency concluded that diabetes-related factors were unlikely to have contributed to 50 of those incidents. The results have helped the FAA determine that it is possible to use a more flexible certification process without compromising aviation safety.
Potential Impact on Thousands of Applicants
The proposed changes could have a significant impact on applicants who currently face extensive administrative and regulatory requirements due to non-insulin-treated diabetes. The FAA estimates that roughly 3,000 applicants each year could receive medical certification without being delayed by special-issuance review under the proposed framework.
The change could also reduce costs associated with the additional documentation and review process. Over five years, the FAA estimates combined industry and government savings of between $39.70 million and $80.19 million, depending on the scenario. The FAA's share of those savings is estimated at approximately $835,000.
What the Proposal Means for Pilots
If adopted, the rule would represent a shift towards a more individualised approach to assessing diabetes among aviation medical applicants. Rather than automatically triggering FAA special-issuance proceedings based primarily on the medication used to manage the condition, many pilots with non-insulin-treated diabetes could have their medical fitness assessed directly by an AME.
The proposal nevertheless maintains additional scrutiny where it is considered necessary, particularly for insulin-treated diabetes and higher-risk cases. The FAA is now seeking public comment before deciding whether to finalise the proposed rule.
Until any final rule takes effect, the current medical certification requirements remain in place. For pilots affected by diabetes-related medical certification requirements, the proposal could eventually provide a simpler and more efficient path to certification while maintaining the FAA's focus on flight safety.
Key Facts
The FAA has proposed allowing many pilots with non-insulin-treated diabetes mellitus (NIDDM) to be certified directly by Aviation Medical Examiners (AMEs).
The proposal would reduce reliance on the FAA's special-issuance review process for eligible applicants.
Pilots who require insulin for diabetes management would still require FAA special-issuance assessment.
AMEs would continue to have the authority to refer higher-risk diabetes cases to the FAA when appropriate.
The FAA says advances in diabetes management and monitoring support a more flexible certification approach.
The agency reviewed 51 fatal accidents involving pilots using non-insulin diabetes medications between 2008 and 2025 and found diabetes-related factors were unlikely to have contributed to 50 of them.
The FAA estimates that approximately 3,000 applicants each year could benefit from the proposed changes.
Combined industry and government savings are estimated at between $39.70 million and $80.19 million over five years.
Public comments on the Notice of Proposed Rulemaking (NPRM) are open until 5 October 2026.
Current FAA medical certification requirements remain unchanged unless the proposed rule is adopted.
Related Articles
Planning growth, fleet changes or seasonal operations in 2026? Contact Brookfield to discuss your staffing and consultancy needs. Email: info@brookfieldav.com
Explore our full range of recruitment services, connecting aviation businesses with skilled pilots, aircraft engineers and industry professionals worldwide.
Author: Shreya Majumder Aviation staffing and consultancy insights LinkedIn
